Your browser doesn't support javascript.
loading
Evaluation of Multisite Programmatic Bundle to Reduce Unnecessary Antibiotic Prescribing for Respiratory Infections: A Retrospective Cohort Study.
Ilges, Dan; Jensen, Kelsey; Draper, Evan; Dierkhising, Ross; Prigge, Kimberly A; Vergidis, Paschalis; Virk, Abinash; Stevens, Ryan W.
Afiliação
  • Ilges D; Department of Pharmacy Services, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Jensen K; Department of Pharmacy Services, Mayo Clinic Health System-Southeast Minnesota, Austin, Minnesota, USA.
  • Draper E; Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota, USA.
  • Dierkhising R; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.
  • Prigge KA; Division of Family Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Vergidis P; Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Virk A; Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Stevens RW; Department of Pharmacy Services, Mayo Clinic Health System-Southeast Minnesota, Austin, Minnesota, USA.
Open Forum Infect Dis ; 10(12): ofad585, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38111752
ABSTRACT

Background:

The aim of this study was to evaluate the frequency of unnecessary antibiotic prescribing for Tier 3 upper respiratory infection (URI) syndromes across the Mayo Clinic Enterprise before and after a multifaceted antimicrobial stewardship intervention, and to determine ongoing factors associated with antibiotic prescribing and repeat respiratory healthcare contact in the postintervention period.

Methods:

This was a quasi-experimental, pre/post, retrospective cohort study from 1 January 2019 through 31 December 2022, with 12-month washout during implementation from 1 July 2020 through 30 June 2021. All outpatient encounters, adult and pediatric, from primary care, urgent care, and emergency medicine specialties with a Tier 3 URI diagnosis were included. The intervention was a multifaceted outpatient antibiotic stewardship bundle. The primary outcome was the rate of antibiotic prescribing in Tier 3 encounters. Secondary outcomes included 14-day repeat healthcare contact for respiratory indications and factors associated with persistent unnecessary prescribing.

Results:

A total of 165 658 Tier 3 encounters, 96 125 in the preintervention and 69 533 in the postintervention period, were included. Following intervention, the prescribing rate for Tier 3 encounters decreased from 21.7% to 11.2% (P < .001). Repeat 14-day respiratory healthcare contact in the no antibiotic group was lower postintervention (9.9.% vs 9.4%; P = .004). Multivariable models indicated that increasing patient age, Charlson comorbidity index, and primary diagnosis selected were the most important factors associated with persistent unnecessary antibiotic prescribing.

Conclusions:

Outpatient antibiotic stewardship initiatives can reduce unnecessary antibiotic prescribing for Tier 3 URIs without increasing repeat respiratory healthcare contact. Advancing age and number of comorbidities remain risk factors for persistent unnecessary antibiotic prescribing.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos